Northeast Financial Consultants Inc - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 103 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Northeast Financial Consultants Inc ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q4 2022$255,058
-36.9%
4,629
-49.3%
0.02%
-43.3%
Q3 2022$404,000
-54.3%
9,129
-49.6%
0.03%
-51.6%
Q2 2022$884,000
+0.2%
18,1290.0%0.06%
+21.6%
Q1 2022$882,000
+14.1%
18,1290.0%0.05%
+8.5%
Q4 2021$773,000
-44.2%
18,129
-49.8%
0.05%
-48.9%
Q3 2021$1,385,000
+38.6%
36,129
+2.1%
0.09%
+37.3%
Q2 2021$999,00035,3830.07%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$367,614,94198.94%
Nan Fung Group Holdings Ltd 368,665$12,081,1529.78%
venBio Partners LLC 1,035,396$33,929,9279.62%
Vivo Capital, LLC 2,606,247$85,406,7149.36%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 314,500$10,306,1653.47%
AlphaCentric Advisors LLC 122,000$3,997,9402.27%
ASHFORD CAPITAL MANAGEMENT INC 434,148$14,227,0302.09%
Altium Capital Management LP 117,000$3,834,0902.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 595,490$19,514,2071.90%
TANG CAPITAL MANAGEMENT LLC 271,200$8,887,2241.25%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders